A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome

Crit Care. 2021 May 6;25(1):166. doi: 10.1186/s13054-021-03589-3.

Tiffany Pascreau^{1

2}, Colas Tcherakian³, Benjamin Zuber⁴, Eric Farfour⁵, Marc Vasse^{5

6}, Philippe Lassalle^{7

8}

¹ Department of CLINICAL Biology, Foch Hospital, 40 rue Worth, 92150, Suresnes, France. t.pascreau@hopital-foch.com.
² INSERM UMR_S 1176, University Paris-Sud, University Paris-Saclay, Le Kremlin-Bicêtre, France. t.pascreau@hopital-foch.com.
³ Department of Pneumology, Foch Hospital, Suresnes, France.
⁴ Department of Medical and Surgical Intensive Care Unit, Foch Hospital, Suresnes, France.
⁵ Department of CLINICAL Biology, Foch Hospital, 40 rue Worth, 92150, Suresnes, France.
⁶ INSERM UMR_S 1176, University Paris-Sud, University Paris-Saclay, Le Kremlin-Bicêtre, France.
⁷ Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d'Infection et d'Immunité de Lille, Equipe immunité pulmonaire, Lille, France.
⁸ Biothelis, 59000, Lille, France.

No abstract available

MeSH terms